Italia markets closed

Baxter International Inc. (BAX)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
40,13-0,10 (-0,25%)
Alla chiusura: 04:00PM EDT
39,70 -0,43 (-1,07%)
Dopo ore: 04:44PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente40,23
Aperto40,21
Denaro40,13 x 800
Lettera40,18 x 800
Min-Max giorno39,97 - 40,42
Intervallo di 52 settimane31,01 - 50,21
Volume1.961.815
Media Volume3.611.125
Capitalizzazione20,44B
Beta (5 anni mensile)0,63
Rapporto PE (ttm)N/D
EPS (ttm)-0,15
Prossima data utili02 mag 2024
Rendimento e dividendo (futuro)1,16 (2,88%)
Data ex dividendo29 feb 2024
Stima target 1A45,00
  • GlobeNewswire

    CORRECTION – Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing

    Tigris patient enrollment momentum continues reaching 72 The Company anticipates three additional trial sites to be activated in Q3 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CORRECTION FROM SOURCE: Spectral Medical Inc. A correction from source is being issued with respect to the press release titled, Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing, released on September 7, 2023, at 7:00 am ET. There was an

  • GlobeNewswire

    Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing

    Tigris patient enrollment momentum continues reaching 72 The Company anticipates three additional trial sites to be activated in Q3 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the “Company”) is pleased to announce that it has closed its previously announced ”bought deal” private placement of 9.0% convertible unsecured senior notes due November 1, 2026